ExPharma Limit has announced the acquisition of Ireland’s Nemysis Limited. Financial Terms have not been made public. Nemysis has a large IP platform of compounds potentially useful for the treatment of symptoms associated with Celiac Disease. Danilo Casadei Massari, the …
Seventure beefs up investment committee with two additions – Expharma Ltd
Seventure Partners has added Danilo Casadei Massari and Dr. Thomas Werner to its health for life capital fund investment committee. Massari was a founder and president of CM&D Pharma Ltd, which was sold to Nestle Health Science while Werner is …
Psychobiotics: Modulation of gut microbiota may ‘hold the key to’ neuropsychological disorders
The majority of the science for probiotics has focused on gut health, but as the understanding of the gut and the microbiome increases, probiotics are increasing linked to a range of beneficial effects, from weight management to immune support and …
Novel food legislation faces hold-up as Member States reject Parliament’s ‘right to veto’
The long running process to develop a new centralised legislative procedure for novel food approvals has hit the rocks again – meaning major delays and backlogs are now on the cards, warn industry insiders. The legislative process hit its latest …
Which came first, the health or the supplement?
The healthier a person is the more likely they are to take food supplements – which could distort links between the products and health outcomes, say Danish researchers. The study, which looked at 54948 Danish people aged 5064, used a …